Cryo-Cell Intl Inc (CCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 02-2026 | 11-2025 | 08-2025 | 05-2025 | 02-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 47 | -2,429 | 1,388 | 639 | 283 |
| Depreciation Amortization | 347 | 1,389 | 1,054 | 695 | 345 |
| Income taxes - deferred | N/A | -2,819 | N/A | N/A | N/A |
| Accounts receivable | -183 | -406 | -305 | 11 | -174 |
| Accounts payable and accrued liabilities | 431 | 1,000 | 741 | 371 | 735 |
| Other Working Capital | -355 | 2,838 | -51 | -835 | -274 |
| Other Operating Activity | 365 | 5,905 | 1,371 | 781 | 39 |
| Operating Cash Flow | $652 | $5,479 | $4,198 | $1,661 | $954 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -67 | -116 | -48 | -10 | -62 |
| Purchase Of Investment | -507 | -3,648 | -3,160 | -2,574 | -600 |
| Sale Of Investment | 594 | 2,788 | 2,523 | 793 | 374 |
| Investing Cash Flow | $19 | $-975 | $-686 | $-1,790 | $-288 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,200 | 8,800 | 6,800 | 6,800 | 2,800 |
| Debt Repayment | -40 | -148 | -110 | -74 | -34 |
| Common Stock Issued | N/A | 23 | 23 | N/A | N/A |
| Common Stock Repurchased | N/A | -170 | -170 | -89 | N/A |
| Dividend Paid | N/A | -3,231 | -3,231 | -3,231 | -2,021 |
| Other Financing Activity | -1,900 | -10,020 | -7,120 | -3,700 | -1,750 |
| Financing Cash Flow | $-740 | $-4,745 | $-3,808 | $-294 | $-1,004 |
| Beginning Cash Position | 319 | 561 | 561 | 561 | 561 |
| End Cash Position | 250 | 319 | 265 | 138 | 223 |
| Net Cash Flow | $-69 | $-242 | $-296 | $-424 | $-338 |
| Free Cash Flow | |||||
| Operating Cash Flow | 652 | 5,479 | 4,198 | 1,661 | 954 |
| Capital Expenditure | -67 | -231 | -163 | -125 | -62 |
| Free Cash Flow | 585 | 5,248 | 4,035 | 1,537 | 892 |